Brain metastasis responding to gefitinib alone
Publication in refereed journal

Times Cited
Web of Science22WOS source URL (as at 20/09/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractA woman with stage IIIb non-small cell lung cancer (NSCLC) developed disease progression with brain metastases during chemotherapy. Due to unusual circumstances, the patient received gefitinib alone, without the use of corticosteroid treatment or radiotherapy. There was a dramatic clinical improvement within 1 week. Followup magnetic resonance imaging of the brain 1 month later showed decreases in both the size and number of brain metastases. The patient remains well 9 months after initiation of gefitinib. It is proposed that gefitinib may have a role in treatment of brain metastases from NSCLC. Copyright (C) 2004 S. Karger AG, Basel.
All Author(s) ListPoon ANY, Ho SSM, Yeo W, Mok TSK
Journal nameOncology
Volume Number67
Issue Number2
Pages174 - 178
LanguagesEnglish-United Kingdom
Keywordsbrain metastases; chemotherapy; gefitinib; lung cancer; metastases; radiotherapy
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2021-21-09 at 00:23